Effectiveness of pancreatic enzyme replacement therapy for patients with unresectable pancreatic cancer; a prospective cohort study
Phase 2
- Conditions
- unresectable pancreatic cancer
- Registration Number
- JPRN-UMIN000040392
- Lead Sponsor
- Department of Gastroenterology, Japanese Red Cross Okayama Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1.severe complication 2.disability of oral intake 3.Inflammatory bowel disease 4.ECOG scale of performance status 3-4
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum albumin at 3 months compare with historical control
- Secondary Outcome Measures
Name Time Method compare with historical control below 1.serum total protein at 3 months 2.HbA1c at 3 months 3.how long days patients could receive chemotherapy 4.over all survival 5.body mass index at 3 months 6.how many pancreatic enzyme drugs patients could have at 3 months